Suppr超能文献

信使核糖核酸疗法:新型疫苗接种及其他应用

mRNA therapeutics: New vaccination and beyond.

作者信息

Wei Huan-Huan, Zheng Liangliang, Wang Zefeng

机构信息

Bio-med Big Data Center, CAS Key Laboratory of Computational Biology, CAS Shanghai Institute of Nutrition and Health, Shanghai 200032, China.

CirCode BioMedicine, Pudong, Shanghai 200131, China.

出版信息

Fundam Res. 2023 Mar 16;3(5):749-759. doi: 10.1016/j.fmre.2023.02.022. eCollection 2023 Sep.

Abstract

The idea of mRNA therapy had been conceived for decades before it came into reality during the Covid-19 pandemic. The mRNA vaccine emerges as a powerful and general tool against new viral infections, largely due to its versatility and rapid development. In addition to prophylactic vaccines, mRNA technology also offers great promise for new applications as a versatile drug modality. However, realizing the conceptual potential faces considerable challenges, such as minimal immune stimulation, high and long-term expression, and efficient delivery to target cells and tissues. Here we review the applications of mRNA-based therapeutics, with emphasis on the innovative design and future challenges/solutions. In addition, we also discuss the next generation of mRNA therapy, including circular mRNA and self-amplifying RNAs. We aim to provide a conceptual overview and outlook on mRNA therapeutics beyond prophylactic vaccines.

摘要

在新冠疫情期间mRNA疗法成为现实之前,其概念已构思了数十年。mRNA疫苗作为一种对抗新病毒感染的强大通用工具而出现,这在很大程度上归功于其多功能性和快速研发。除了预防性疫苗外,mRNA技术作为一种通用的药物形式在新应用方面也前景广阔。然而,要实现这一概念上的潜力面临着诸多挑战,如最小化免疫刺激、高且长期的表达以及有效递送至靶细胞和组织。在此,我们综述基于mRNA的疗法的应用,重点关注创新设计以及未来的挑战与解决方案。此外,我们还讨论了下一代mRNA疗法,包括环状mRNA和自我扩增RNA。我们旨在提供除预防性疫苗之外的mRNA疗法的概念性概述和展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/11197805/edae72f40f88/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验